Wolhusen
Switzerland
41
2026-01-29
33
2026-01-27
These are the the leading inventors for applications assigned to GEISTLICH PHARMA AG:
GEISTLICH PHARMA AG based in Wolhusen, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMBINATION THERAPY FOR TREATING CANCERS
#2 | 2026-01-22COMBINATION THERAPY FOR TREATING CANCERS
#3 | 2024-11-07 β Patent 12,534,443 granted on 2026-01-27PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS
#4 | 2024-06-20ANTIMICROBIAL AND ANTICANCER AGENTS
#5 | 2023-12-07APPLICATOR OF A SPONGEOUS COLLAGEN MEMBRANE AND KIT COMPRISING SUCH APPLICATOR AND MEMBRANE
#6 | 2023-05-25 β Patent 11,999,709 granted on 2024-06-04Processes for preparing oxathiazin-like compounds
#7 | 2022-10-13METHODS AND COMPOSITIONS FOR INHIBITING GAPDH
#8 | 2022-10-13 β Patent 12,514,847 granted on 2026-01-06OXATHIAZIN_DIOXIDE FOR TREATING, PREVENTING, INHIBITING OR REDUCING CYTOKINE RELEASE
#9 | 2022-10-06OXATHIAZIN COMPOUNDS FOR INHIBITING GAPDH
#10 | 2022-01-27 β Patent 11,571,494 granted on 2023-02-07Method for treating subjects suffering from chronic ulcers
#11 | 2021-06-03 β Patent 11,591,302 granted on 2023-02-28Processes for preparing oxathiazin-like compounds
#12 | 2020-12-17 β Patent 11,357,891 granted on 2022-06-14Collagen matrix or granulate blend of bone substitute material
#13 | 2020-12-17 β Patent 10,960,107 granted on 2021-03-30Collagen matrix or granulate blend of bone substitute material
#14 | 2020-12-17 β Patent 10,918,592 granted on 2021-02-16Injectable aqueous implant formulation containing ascorbic acid
#15 | 2020-11-05 β Patent 11,633,519 granted on 2023-04-25Dried implant composition and injectable aqueous implant formulation
#16 | 2020-10-15 β Patent 10,869,949 granted on 2020-12-22Method for treating subjects suffering from chronic ulcers
#17 | 2020-01-16 β Patent 10,646,615 granted on 2020-05-12Bone substitute material
#18 | 2019-12-26 β Patent 10,968,190 granted on 2021-04-06Processes for preparing oxathiazin-like compounds
#19 | 2019-07-11 β Patent 10,646,619 granted on 2020-05-12Bone substitute material
#20 | 2019-07-11 β Patent 10,695,461 granted on 2020-06-30Dried implant composition and injectable aqueous implant formulation
#21 | 2019-06-20 β Patent 11,351,287 granted on 2022-06-07Bone substitute material
#22 | 2019-03-28 β Patent 10,736,902 granted on 2020-08-11Method of treating triple negative breast cancer
#23 | 2019-03-21 β Patent 10,544,114 granted on 2020-01-28Process for preparing oxathiazin-like compounds
#24 | 2018-12-27 β Patent 10,392,355 granted on 2019-08-27Processes for preparing oxathiazin-like compounds
#25 | 2018-12-06 β Patent 10,835,640 granted on 2020-11-17Resorbable crosslinked form stable membrane for use outside the oral cavity
#26 | 2018-09-13 β Patent 10,300,171 granted on 2019-05-28Resorbable crosslinked form stable membrane
#27 | 2017-07-13 β Patent 9,844,555 granted on 2017-12-19Oxathiazine derivatives as antibacterial and anticancer agents
#28 | 2016-06-16 β Patent 9,655,997 granted on 2017-05-23Collagen sponge
#29 | 2016-06-09 β Patent 9,624,187 granted on 2017-04-18Oxathiazine derivatives as antibacterial and anticancer agents
#30 | 2016-05-26 β Patent 10,029,028 granted on 2018-07-24Biomimetic collagen-hydroxyapatite composite material
#31 | 2015-07-02HYDROPHILIC PHOSPHATE GROUP CONTAINING DEHYDRATED PARTIALLY PURIFIED BONE REPLACEMENT MATERIAL
#32 | 2015-07-02 β Patent 9,241,943 granted on 2016-01-26Oxathiazine derivatives as antibacterial and anticancer agents
#33 | 2013-12-26 β Patent 9,066,995 granted on 2015-06-30Bone substitute material
#34 | 2013-07-25 β Patent 8,852,617 granted on 2014-10-07Antimicrobial dental care preparation
#35 | 2013-04-11 β Patent 9,028,866 granted on 2015-05-12Methods and compositions for oral pharmaceutical therapy
#36 | 2013-01-10 β Patent 8,852,580 granted on 2014-10-07Method and device for synovial cell-charged collagen membrane or gel
#37 | 2012-05-24 β Patent 8,734,524 granted on 2014-05-27Bone substitute material
#38 | 2012-04-05 β Patent 8,491,592 granted on 2013-07-23Device for the application of bone substitute material
#39 | 2011-11-10 β Patent 8,992,946 granted on 2015-03-31Method and membrane for tissue regeneration
#40 | 2011-11-03 β Patent 9,770,538 granted on 2017-09-26Method and membrane for skin regeneration
#41 | 2009-06-25USE OF TAUROLIDINE TO TREAT TUMORS
Also check out GEISTLICH PHARMA AG's (Wolhusen, Switzerland) applicant profile with 28 patent applications submitted.
3371 β